Outcomes of stereotactic body radiotherapy for large lung lesions: Is tumor size still a limiting factor?
Objective: Evidence regarding stereotactic body radiotherapy (SBRT) for large lung lesions remains limited because most prospective trials excluded tumors ≥5 cm owing to concerns regarding treatment-related adverse events (AEs). We evaluated the efficacy and safety of SBRT in patients with large (≥4 cm) primary lung le...